INOVIO PHARMACEUTICALS, INC.
Last · —$0.99-0.01 (-1.00%)live · yahoo · 1h ago
Market cap$101.95M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-12
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 5747.8%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -130000.0%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -135637.2%
- Cash Runway Low — Cash runway ~0.5 years
- Accumulated Deficit High — Accumulated deficit / equity 7533%
- Rd Intensity High — R&D/Revenue 82957.4%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.20
Est. revenue
0
Earnings transcripts
Documents
FormReporting forFiledFlags